The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COMy 2019 | Prof. Mohty on COMy 2019
In this interview at the Controversies in Multiple Myeloma (COMy) 2019 World Congress in Paris, France, Mohamad Mohty, MD, PhD of Saint-Antoine Hospital, Paris, France, discusses some of the highlights from the 5th COMy Congress, which had a record number of participants. Prof. Mohty discusses the movement towards a focus on targeting the microenvironment to synergize with drugs, investigating resistance mechanisms and further enhancing drug efficacy.
